Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. The Dutch multicentre trial

PC van de Meeberg, RHJ Houwen, M (Maarten) Sinaasappel, HGM Heijerman, ChMA Bijleveld, GP Van Berge - Henegouwen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)588-589
Number of pages2
JournalBritish Medical Journal
Volume12
Publication statusPublished - 1997

Research programs

  • EMC MM-04-54-07

Cite this